Protein Modification by &bgr;-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance

E-ISSN： 2212-3334|4|2|161-171

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.4, Iss.2, 2010-06, pp. : 161-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patents in Targets and Drugs for Insulin Resistance: Correlation with Inflammatory Mediators

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 247-254

Bentham Science Publishers

Access to resources Recommend Favorite

The Two Faces of Protein Palmitoylation in Islet &bgr;-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 3, 2013-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Degludec: A Novel Basal Insulin

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 18-23

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on Oral Insulin

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 3, 2010-01 ,pp. : 248-252

Bentham Science Publishers

Access to resources Recommend Favorite

Ultra-Fast Acting Insulin Analogues

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 8, Iss. 2, 2014-05 ,pp. : 117-123

Bentham Science Publishers

Access to resources Recommend Favorite